logo

Search

3D Bioprinting Market

3D Bioprinting Market By Component (3D Bioprinters, Bio-inks, Software, Consumables), By Material (Living Cells, Hydrogels, Extracellular Matrices, Other Materials), By Technology (Magnetic Levitation, Inkjet-based, Syringe-based, Laser-based, Others), By End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals), Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2024-2031

Report ID : 3176 | Publisher ID : Meta | Published : 2024-12-31 | Pages : 255

Licence Type
$ 3550
$ 5350
$ 7100

MARKET OVERVIEW 

The Global 3D Bioprinting market and its industry will be the new landmark of modern healthcare and regenerative medicine. This market, with advancing technology, is going to reshape the future of medical research, tissue engineering, and drug development. Using 3D printing technology, this process allows for layer by layer creation of biological tissues, opening doors to unprecedented medical treatments and innovations. 

Near-term, Global 3D Bioprinting Market will see further development of its first applications in the research and pharmaceutical industries. Newer technologies of bioinks, cellular materials, and higher software will come into market for raising degrees of precision for tissue modeling and drug testing. It will come with meaningful developments in generating patient-specific treatments and designed therapies, along with complexities in tissue structure for the implants. 

The size of the Global 3D Bioprinting market, from the perspective of changing organ and tissue printing, would be further expanded through customized medicine, biotechnology, and even cosmetics. Established in tissue regeneration, using it in conjunction with devices for medical applications towards creating customized prosthetics or implants will be taken to new heights. This would give rise to a very personalized prosthetic solution able to meet individualistic demands, thus giving rise to comfort and practicality not previously achieved. 

As new innovations arise, the improvements in functionality and efficiency within 3D bioprinting systems will arise. More complex tissues, and more importantly, structural organs necessary for clinical applicability will be printed as time goes by. For instance, it will be a great success when human organs such as kidneys and livers become printable, fully functional organs. It will end the long waiting list of people for transplants and bring down waiting times. 

The Global 3D Bioprinting market will also feel the shifts in the regulatory landscape. With bioprinted tissues and organs now entering widespread use in medicine, regulatory bodies will only streamline their rules and requirements so that such treatments don’t harm and are found effective. This will boost even more confidence in such solutions from the medical profession to the patient’s hands. A successful framework for bioprinted medical solutions will be built in partnership between providers, research organizations, and regulators. 

Educational institutions and research organizations will be the source of innovation for the Global 3D Bioprinting market. More people will be trained with the knowledge of bioprinting technologies and applications as the knowledge base continues to grow. This would ensure that the workforce was qualified to develop, operate, and improve bioprinting technologies. Besides, this partnership between the academic institutes and the private companies would encourage a place where ideas can be translated into marketable solutions with rapidity. 

With regard to the future of the Global 3D Bioprinting market, there are possible areas of application that are not limited only to healthcare but more broadly to food production and even environmental conservation. Integrated with sustainable practices, 3D bioprinting can be a key step to reducing waste and bringing in alternative protein sources into markets. With these as its potential avenues, impacts will most likely stretch out from its initial boundaries while revolutionizing industries worldwide. 

The Global 3D Bioprinting market and industry are set to experience quite tremendous growth. With every step of advancement in the bioprinting technology, the scope of application will expand, thereby entering into healthcare, research, and even environmental sectors. The developments within this market will undoubtedly transform industries in the future, unlocking through 3D bioprinting the keys that can solve some of the world’s most challenging medical and environmental challenges. 

Global 3D Bioprinting market is estimated to reach $2,813.40 Million by 2031; growing at a CAGR of 12.7% from 2024 to 2031.

GROWTH FACTORS 

The Global 3D Bioprinting market is an increasingly emerging technology space that can create many possibilities in health care, research, and manufacturing. It involves biological structure creation using 3D printing technology, which has given room for the medical world to take revolutions in organ regeneration and drug testing. The industry has gone through many factors to encourage growth and challenges shaping opportunities into the future trajectory of the field. 

Another prime mover of the market is the growing demand for organ transplants and tissue engineering. As there is an immense gap between organ donors and recipients, 3D bioprinting provides hope to bridge this gap by developing artificial organs and tissues. Besides this, the technology is of benefit to pharmaceutical research in that drugs can be tested on the tissues that are bioprinted, which lowers the number of animal experiments required and speeds up the drug development processes. Moreover, with advancements in technologies, like the incorporation of stem cells and biomaterials, has helped expand the uses of 3D bioprinting, which in turn adds to its development. 

Investment in research and development is a huge growth driver for this market. Governments, private companies, and academic institutions are putting tremendous investment into this technology, as it promises solutions to many of the burning questions facing the health sector. The third element that is pushing forward this innovation is the cooperation of major players in the market in driving innovation forward; now impossible breakthroughs are turned into a possibility. 

However, it does have some market barriers. The cost that the high technology and materials charge the bioprinting processes are not affordable. Additionally, the regulatory concerns in the use of the human cells and tissues put significant hurdles to be jumped by the bioprinting technology. These reasons can delay the integration into healthcare mainstream. 

Despite these hindrances, the future outlook for the Global 3D Bioprinting market seems positive. Low-cost material sciences and printing techniques are expected to enhance much better in the future with advancing new techniques; this improves the scalability of applications related to bioprinting. Further improvement in clarity of regulations will induce more investment and collaboration effort in the future. Some emerging economies will also boost growth in the coming years, primarily because of their adoption of these technologies toward their rising health care needs in the near future. 

This field is going to redefine medical practice in the coming years. Beyond healthcare, industries like cosmetics and food production shall find opportunities. The global 3D bioprinting market is going to revolutionize many sectors; solutions that were once believed to be impossible will open its future both excitingly and impactfully. 

MARKET SEGMENTATION 

By Component  

The Global 3D Bioprinting market has gained great interest in the last few years, primarily because of the fact that it can change the scenario of many sectors, like healthcare and biotechnology. This technology produces complex structures composed of living cells, biomaterials, and other elements by using 3D printing. Technology advancement and a growing demand for personalized medicine, tissue engineering, and drug testing are expected to bring about substantial growth in this market. The market can be segmented into different parts such as 3D bioprinters, bio-inks, software, and consumables. Each of them has a significant role to play in the development and application of 3D bioprinting technologies. 

3D bioprinter segment is expected to grow further as it acts as core equipment needed for the process. These will enable the precise layer-by-layer deposition of living cells and biomaterials in the design of custom tissues and organs. With time, the printers themselves will evolve to provide a better resolution, faster speeds in printing, and high biological material compatibility. Due to the advancements in the technology, the cost for 3D bioprinting will reduce significantly. Consequently, it becomes within the reach of conducting institutions, health facilities, and even small firms, that operate in the spheres of biotechnology. 

Other aspects of the market also revolve around the bio-inks. These are considered materials to be used while printing cells and structures. Bio-inks are made in such a manner that they resemble human tissues and organs, so one can use them in areas concerning tissue regeneration and disease modeling. In the coming days, the demand for such bio-inks is to be increased as there have been more advanced developments needed in order to sustain cellular growth and tissue formation. These materials have to be compatible with different types of cells, such as stem cells, to ensure a good functioning in the creation of functional biological structures. 

Software connected to the 3D bioprinting process is crucial for the design, simulation, and control of bioprinting operations. With further advancements of technology, software will become so much more intuitive and sophisticated whilst offering users much greater levels of control over the printing process to create increasingly complex yet highly precise structures. All of this will lead to immense acceleration in the integration of 3D bioprinting, not only in areas like regenerative medicine and personal health care, but also where capabilities for designing customized biological structures will be of prime importance. 

The second category, which will increase, consists of consumables. As the interest in the actual bioprinting begins by scaling up the processes so that it becomes reliable and also gets more efficient, there will always be the utilization of consumables such as scaffolds and growth factors and biological agents to keep on pushing it high up. Different consumables to suit a researcher's variety of application in testing drug, or even printing complete organs. 

In the end, the Global 3D Bioprinting market will expand greatly because of further innovation in bioprinter technology, bio-inks, software, and consumables. Growth in all these areas will continue and become very important in enabling advancements beyond the scope in the medical and biotech industries. 

By Material  

The Global 3D Bioprinting market is expanding rapidly as more industries begin to explore this innovative technology. The process of 3D bioprinting uses specialized printers that create three-dimensional structures. These are often made of materials such as living cells, hydrogels, and extracellular matrices, which are important for making functional tissues and organs in medicine but can also be applied in other industries, including pharmaceuticals and cosmetics. With advancing technology, the demand for high-quality and reliable 3D bioprinted products will grow, and it would have an impact on a host of industries. 

When considering materials used in 3D bioprinting, it is observed that it can be segmented into categories. Living cells are an essential material in this space. The use of living cells has enabled researchers and manufacturers to create complex, biologically accurate models of tissues and organs. This is the most crucial aspect in medical science research because scientists are on their way to discovering custom treatments and even printing organs. The advancement of technology will inevitably bring a surge in utilizing living cells in bioprinting, thus creating the backbone of future innovations in medicine. 

Hydrogels also participate significantly in the Global 3D Bioprinting market. Water-based materials assist in creating a supportive structure for cells and tissues to thrive and interact. Hydrogels can be engineered to give the properties of natural tissues, which makes them applicable in scaffolding tissue-engineering. As the research goes on, hydrogels are expected to become further sophisticated, with improved property in cell growth and also complex tissue structures. 

Another important material in the market is extracellular matrices, which are the natural scaffolds found in the body and support cells and tissues. Extracellular matrices are used to build environments that mimic the actual tissues in 3D bioprinting for cell growth and tissue development. With continuous research, ECMs will become ever more important in the generation of functional, life-like tissues for medical applications. 

Other materials in the Global 3D Bioprinting market include other synthetic and natural substances which support the formation of specific structures. These materials, although they may not be as applied to living cells, hydrogels, or ECMs, are very critical in specific bioprinting applications. 

By Technology  

The Global 3D Bioprinting market is rapidly increasing and growing with significant technological advances defining its future. Industries need innovative solutions to face health care and manufacturing problems. Hence, 3D bioprinting emerges as a promising area for them. As different technologies are playing a key role in the development of the market, which has shown significant potential already, this market will continue to develop in the future. 

The technology behind 3D bioprinting is diverse, and several methods are being explored to improve the precision and efficiency of printing complex biological structures. One of the key technologies in this market is Magnetic Levitation. It uses magnetic fields to manipulate and position cells or materials during the printing process. Through high precise, delicate structures, the formation of very detailed biological prints holds great advantage with Magnetic Levitation. With further enhancement of this technology, improved outcomes can be expected and observed, especially in aspects such as tissue engineering or organ printing. 

Another big player in the Global 3D Bioprinting market is inkjet-based bioprinting. In this method, by a very controlled manner droplets of bioink drop onto the substrate. Inkjet-based bioprinting has been favored for its precision and speed, which makes it ideal for creating functional tissues and organs. With the improvement of the technology, inkjet printers will probably be able to print larger and more complex biological structures, opening new avenues in medical research and personalized medicine. 

The most commonly practiced technique is the syringe-based bioprinting technique where bioinks are extruded through a syringe, layer by layer, creating 3D structures. This technique would be considered to have more versatility than others in being able to print a number of different tissues. Some future prospects for syringe-based bioprinting would focus on the printed structure consistency as well as improving new types of bioinks that will better mimic properties of human tissue. 

Other such technologies that will continue playing important roles in the Global 3D Bioprinting market are laser-based bioprinting, which uses laser energy for the precise control of deposition of bioinks. In this method, high-resolution and accuracy are very significant for the creation of intricate, highly functional tissues. As the technology advances, there is a possibility that it may be applied in different fields, such as in the development of drugs and in regenerative medicine. 

Some emerging technologies also add to this expanded growth in the Global 3D Bioprinting market. These include other ways to create these biological structures that may even introduce a whole new aspect, providing greater capabilities toward the limitation of what it is currently possible to develop and thereby alleviate the issue facing the health care sector. The development of bioprinting technology will likely experience revolutionary changes in fields concerning medical treatment, tissue regeneration, and even organ transplants. As the industry grows, the combination of these advanced technologies will evolve the way we approach the healthcare and medical research sphere. 

By End User  

The global 3D bioprinting market is an exciting, rapidly evolving field that is full of promises for the future. Using 3D printing for the generation of biological tissues and organs is making it possible for tremendous developments in healthcare, research, and biotechnology. This power can actually revolutionize industries, thereby bringing into practice new methodologies of drug development, treatment of medicine, and even organ transplantation. These have more end-users coming from other influences than before, such as academia and research institutes, pharmaceutical and biotechnology companies, and hospitals. 

It is through academic and research institutes that the growth of the global 3D bioprinting market is found. Academic and research institutes help research and develop, pushing 3D bioprinting technology further than what could be possible. As scientists and researchers continue to discover new applications and techniques, academic institutes will be in the leading edge of innovation in this field. These developments, along with new materials and bioprinting technologies, will also play their roles in preparing the next generations of experts. Academic and research institutes will also interact further with other sectors in extending further the capabilities of 3D bioprinting in the future. 

A pharmaceutical and biotechnology companies are the other key actors in the global 3D bioprinting market. They are using bioprinting to create more realistic and efficient drug testing models, which will minimize the necessity of animal testing and thereby speed up the drug developmental process. Pharmaceutical companies will, therefore, be able to run tests on the effects that new drugs have on different patients in a more detailed and cost-effective manner when using 3D printed tissues. The technology, therefore, is likely to improve personalized medicine by making it easier to develop patient-specific types of drug treatments. In the future, pharmaceutical and biotechnology companies are likely going to continue to invest quite heavily in 3D bioprinting technology that brings more innovative and targeted solutions to market. 

Hospitals are also integrating 3D bioprinting into their medical practices. This offers a wide range of potential benefits. Probably one of the most interesting is the possibility of designing patient-specific prosthetics and implants. As the technology becomes more advanced, the possibility for the hospitals to use 3D bioprinting for organs and tissues transplantation is high. This could, therefore, decrease the number of waiting transplant lists and suffering by a considerable margin. The healthcare industry is very likely to become 3D-printing-enabled in the future where more hospitals will be using bioprinting technology as the norm in medical care and will be delivering patient-centric care. 

The global 3D bioprinting market will continue to evolve and expand, driven by key players like academic institutes, pharmaceutical and biotechnology companies, and hospitals. As the technology advances, it will bring new opportunities for research, drug development, and medical treatments, shaping the future of healthcare and biotechnology in profound ways.

 

Forecast Period  

2024-2031 

Market Size in 2024 

$1,217.87 million 

Market Size by 2031 

$2,813.40 Million 

Growth Rate from 2024 to 2031 

12.7% 

Base Year 

2022 

Regions Covered 

North America, Europe, Asia-Pacific Green, South America, Middle East & Africa 

 

REGIONAL ANALYSIS 

It has shown immense growth in the global 3D bioprinting market, influenced by multiple reasons that cut across various geographies. The technology is proceeding and spreading its applications and influence around the world, thus making it important to conduct a regional analysis to realize the proper impact. 

In North America, the United States, Canada, and Mexico are at the forefront of bioprinting research and development. The U.S. is leading the technological advancement with numerous biotech companies and research institutions investing heavily in the sector. The government support towards innovation in healthcare and biotechnology is also fostering growth in the industry. Canada and Mexico, though not as strong as the U.S., are slowly but surely increasing their participation, with collaborations with global players and growing interest in healthcare innovations. 

Europe is also a hub of various biotech hubs, which makes it a significant player in the 3D bioprinting market. The UK, Germany, France, and Italy stand out because of their well-established healthcare infrastructure and strong research institutions. They are already implementing 3D bioprinting for purposes such as drug development and organ printing, which shows a great commitment to developing the field. Other European countries are also joining the trend and are investing in the development of this technology to enhance health solutions in the region. 

Asian-Pacific nations such as China, Japan, India, and South Korea are on a rising trend of bioprinting activities. The technological base in China and Japan is very well-established, and hence there are good research developments along with its commercial application in bioprinting. India is emerging as a key player, especially with the increasing number of medical research institutions and startups working on bioprinting technologies. South Korea, with its focus on innovation in health technology, is also expanding its role in this market, positioning itself as a leader in medical device manufacturing and regenerative medicine. 

South America is a relatively small market but is growing in the field of 3D bioprinting. Brazil and Argentina are the main countries investing in bioprinting technology. These countries are focusing on developing their research capabilities and have collaborated with global organizations to bring innovation to the healthcare sector. As the market matures, it is expected that more South American countries will explore 3D bioprinting applications to address regional healthcare challenges. 

This market can start to be penetrated through significant investment in advanced technologies like bioprinting, first beginning in Saudi Arabia and UAE, followed by others. Other countries in Africa like South Africa are partnering with other international organizations in this health-related infrastructure to realize its use with the support of 3D bioprinting. Further increase of sector's scale can likely to come from Middle East and Africa. Looking forward, the global 3D bioprinting market will probably be in a continued growth path with regional players increasingly defining its development.

COMPETITIVE PLAYERS 

The global market for 3D bioprinting is rapidly expanding. Key players are driving the directions of this market's developments. With advancing technology, these companies are achieving ground in various areas such as healthcare, tissue engineering, and drug development. Organovo Holdings, Inc., CELLINK AB, and EnvisionTEC GmbH are among the known names in the industry, contributing vastly to the commercialization of 3D bioprinting. All these companies are trying to expand and push the boundaries of what is currently possible. Some try to come up with fully functional tissues and organs while others try to speed up and improve the bioprinting processes in precision. 

For example, Organovo Holdings is notable for its efforts in creating human tissues, which can be used for drug testing with the aim of completely avoiding animal testing. This could significantly improve the way drugs are developed and tested by pharmaceutical companies. CELLINK AB, however, positions itself as a leader in bioprinting materials, offering a variety of bioinks that are essential to produce living tissues. The leading 3D printing solutions provider, EnvisionTEC GmbH, has been able to innovate and push further boundaries in medical and dental sectors by producing highly accurate and customized medical devices through 3D bioprinting. 

Other big players like 3D Systems, Inc., and Allevi Inc. are contributing to this growth by trying to make 3D bioprinting accessible and affordable. These companies provide user-friendly bioprinting platforms that aim to empower researchers and institutions to create complex biological structures. Meanwhile, Regemat 3D S.L. and Merck KGaA are developing advanced bioprinting solutions for regenerative medicine, making it possible to print tissues that can be used in transplants or treatments for various diseases. 

Companies like Cyfuse Biomedical K.K. and Sunp Biotech are taking the technology even further with specialized solutions that can create highly complex and functional tissues. Meanwhile, companies like RegenHU Ltd. and Voxcell Bioinnovation Inc. focus their innovations on improving the entire process, aiming for better precision and efficiency. Poietis, Advanced Solutions Life Sciences, and GeSiM are advancing the field, creating bioinks and developing custom bioprinting solutions for clinical applications. 

The competition in the global 3D bioprinting market is likely to increase in the near future. With Inventia Life Science Pty Ltd, UPM, and CollPlant Biotechnologies Ltd., among others, involved, this market is expected to gain a lot of innovation. This industry will grow exponentially with technologies developed by researchers and companies, which will revolutionize healthcare, making it possible to create customized treatments, and even print an entire organ. These players will significantly influence the future of medicine with increasing demand for 3D bioprinting. 

3D Bioprinting Market Key Segments: 

By Component 

  • 3D Bioprinters 
  • Bio-inks 
  • Software 
  • Consumables 

By Material 

  • Living Cells 
  • Hydrogels 
  • Extracellular Matrices 
  • Other Materials 

By Technology 

  • Magnetic Levitation 
  • Inkjet-based 
  • Syringe-based 
  • Laser-based 
  • Others 

By End User 

  • Academic & Research Institutes 
  • Pharmaceutical & Biotechnology Companies 
  • Hospitals 

Key Global 3D Bioprinting Industry Players 

WHAT REPORT PROVIDES 

  • Full in-depth analysis of the parent Industry 
  • Important changes in market and its dynamics 
  • Segmentation details of the market 
  • Former, on-going, and projected market analysis in terms of volume and value 
  • Assessment of niche industry developments 
  • Market share analysis 
  • Key strategies of major players 
  • Emerging segments and regional growth potential 

1. Market Introduction
1.1. Executive Summary
1.2. Market Definition
1.3. Market Scope
2. Research Methodology
2.1. Primary Research
2.2. Research Methodology
2.3. Assumptions & Exclusions
2.4. Secondary data sources
3. 3D Bioprinting Market Overview
3.1. Report Segmentation & Scope
3.2. Key Market Trend
3.3. Drivers
3.3.1. Growing Demand for Organ Transplantation and Regenerative Medicine
3.3.2. Technological Advancements in 3D Bioprinting Technologies
3.4. Restraints
3.4.1. High Initial Costs and Maintenance of 3D Bioprinting Equipment
3.4.2. Regulatory and Ethical Challenges in Bioprinted Products
3.5. Opportunity
3.5.1. Expansion of Application Areas in Pharmaceutical and Cosmetics Industries
3.6. Porter’s Five Forces Analysis
3.6.1. Porter’s Five Forces Analysis
3.7. Market Share Analysis
4. Component Overview
4.1. Introduction
4.1.1. Market Size & Forecast
4.2. 3D Bioprinters
4.2.1. Market Size & Forecast
4.3. Bio-inks
4.3.1. Market Size & Forecast
4.4. Software
4.4.1. Market Size & Forecast
4.5. Consumables
4.5.1. Market Size & Forecast
5. Material Overview
5.1. Introduction
5.1.1. Market Size & Forecast
5.2. Living Cells
5.2.1. Market Size & Forecast
5.3. Hydrogels
5.3.1. Market Size & Forecast
5.4. Extracellular Matrices
5.4.1. Market Size & Forecast
5.5. Other Materials
5.5.1. Market Size & Forecast
6. Technology Overview
6.1. Introduction
6.1.1. Market Size & Forecast
6.2. Magnetic Levitation
6.2.1. Market Size & Forecast
6.3. Inkjet-based
6.3.1. Market Size & Forecast
6.4. Syringe-based
6.4.1. Market Size & Forecast
6.5. Laser-based
6.5.1. Market Size & Forecast
6.6. Others
6.6.1. Market Size & Forecast
7. End User Overview
7.1. Introduction
7.1.1. Market Size & Forecast
7.2. Academic & Research Institutes
7.2.1. Market Size & Forecast
7.3. Pharmaceutical & Biotechnology Companies
7.3.1. Market Size & Forecast
7.4. Hospitals
7.4.1. Market Size & Forecast
8. 3D Bioprinting Market Regional Overview
8.1. Introduction
8.1.1. Market Size & Forecast
8.2. North America 3D Bioprinting Market
8.2.1. North America Market Size & Forecast, By Country
8.2.2. North America Market Size & Forecast, By Component
8.2.3. North America Market Size & Forecast, By Material
8.2.4. North America Market Size & Forecast, By Technology
8.2.5. North America Market Size & Forecast, By End User
8.2.6. U.S.
8.2.6.1. Market Size and Forecast
8.2.7. Canada
8.2.7.1. Market Size and Forecast
8.2.8. Mexico
8.2.8.1. Market Size and Forecast
8.3. Europe 3D Bioprinting Market
8.3.1. Europe Market Size & Forecast, By Country
8.3.2. Europe Market Size & Forecast, By Component
8.3.3. Europe Market Size & Forecast, By Material
8.3.4. Europe Market Size & Forecast, By Technology
8.3.5. Europe Market Size & Forecast, By End User
8.3.6. Germany
8.3.6.1. Market Size and Forecast
8.3.7. France
8.3.7.1. Market Size and Forecast
8.3.8. UK
8.3.8.1. Market Size and Forecast
8.3.9. Italy
8.3.9.1. Market Size and Forecast
8.3.10. Spain
8.3.10.1. Market Size and Forecast
8.3.11. Rest of Europe
8.3.11.1. Market Size and Forecast
8.4. Asia-Pacific 3D Bioprinting Market
8.4.1. Asia-Pacific Market Size & Forecast, By Country
8.4.2. Asia-Pacific Market Size & Forecast, By Component
8.4.3. Asia-Pacific Market Size & Forecast, By Material
8.4.4. Asia-Pacific Market Size & Forecast, By Technology
8.4.5. Asia-Pacific Market Size & Forecast, By End User
8.4.6. China
8.4.6.1. Market Size and Forecast
8.4.7. Japan
8.4.7.1. Market Size and Forecast
8.4.8. India
8.4.8.1. Market Size and Forecast
8.4.9. South Korea
8.4.9.1. Market Size and Forecast
8.4.10. Australia
8.4.10.1. Market Size and Forecast
8.4.11. South East Asia
8.4.11.1. Market Size and Forecast
8.4.12. Rest of Asia-Pacific
8.4.12.1. Market Size and Forecast
8.5. South America 3D Bioprinting Market
8.5.1. South America Market Size & Forecast, By Country
8.5.2. South America Market Size & Forecast, By Component
8.5.3. South America Market Size & Forecast, By Material
8.5.4. South America Market Size & Forecast, By Technology
8.5.5. South America Market Size & Forecast, By End User
8.5.6. Brazil
8.5.6.1. Market Size and Forecast
8.5.7. Argentina
8.5.7.1. Market Size and Forecast
8.5.8. Rest of South America
8.5.8.1. Market Size and Forecast
8.6. Middle East & Africa 3D Bioprinting Market
8.6.1. Middle East & Africa Market Size & Forecast, By Country
8.6.2. Middle East & Africa Market Size & Forecast, By Component
8.6.3. Middle East & Africa Market Size & Forecast, By Material
8.6.4. Middle East & Africa Market Size & Forecast, By Technology
8.6.5. Middle East & Africa Market Size & Forecast, By End User
8.6.6. GCC Countries
8.6.6.1. Market Size and Forecast
8.6.7. UAE
8.6.7.1. Market Size and Forecast
8.6.8. Saudi Arabia
8.6.8.1. Market Size and Forecast
8.6.9. South Africa
8.6.9.1. Market Size and Forecast
8.6.10. Rest of Middle East & Africa
8.6.10.1. Market Size and Forecast
9. Company Profile
9.1. Organovo Holdings, Inc.
9.1.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.1.2. Organovo Holdings, Inc. Product Category, Application, and Specification
9.1.3. Organovo Holdings, Inc. Financial Performance (2020-2022)
9.1.4. Main Business/Business Overview
9.2. CELLINK AB
9.3. EnvisionTEC GmbH
9.4. 3D Systems, Inc.
9.5. Allevi Inc.
9.6. Regemat 3D S.L.
9.7. Merck KGaA
9.8. Cyfuse Biomedical K.K.
9.9. Sunp Biotech
9.10. RegenHU Ltd.
9.11. Voxcell Bioinnovation Inc.
9.12. Poietis
9.13. Advanced Solutions Life Sciences
9.14. GeSiM (Gesellschaft für Silizium-Mikrosysteme mbH)
9.15. Inventia Life Science Pty Ltd
9.16. UPM
9.17. CollPlant Biotechnologies Ltd.
9.18. Tissuelabs

  • Organovo Holdings, Inc.
  • CELLINK AB
  • EnvisionTEC GmbH
  • 3D Systems, Inc.
  • Allevi Inc.
  • Regemat 3D S.L.
  • Merck KGaA
  • Cyfuse Biomedical K.K.
  • Sunp Biotech
  • RegenHU Ltd.
  • Voxcell Bioinnovation Inc.
  • Poietis
  • Advanced Solutions Life Sciences
  • GeSiM (Gesellschaft für Silizium-Mikrosysteme mbH)
  • Inventia Life Science Pty Ltd

n/a

Frequently Asked Questions

Global 3D Bioprinting market is valued at $1,217.87 million in 2024.
Global 3D Bioprinting market is estimated to grow with a CAGR of 12.7% from 2024 to 2031.
Global 3D Bioprinting market is estimated to reach $2,813.40 million by 2031.
Top players operating in the 3D Bioprinting industry includes Organovo Holdings, Inc., CELLINK AB, EnvisionTEC GmbH, 3D Systems, Inc., Allevi Inc., Re